🇸🇪 Swedish, 7 October 2026, drug repurposing
AI in Drug Repurposing Market to Reach USD 7.7 Billion by 2033
Market expected to expand at 24.5% CAGR driven by precision medicine and rare diseases
The global AI in drug repurposing market was valued at USD 1.3 billion in 2025 and is projected to reach USD 7.7 billion by 2033, with a CAGR of 24.5%. This growth is driven by demand for cost-effective drug development and the increasing prevalence of rare and complex diseases.
Advances in precision medicine, computing power, and cloud infrastructure are accelerating market adoption. AI strengthens the drug repurposing approach by analyzing large biological, chemical, and clinical datasets to identify promising drug-disease associations.
Industry collaborations, such as the partnership between Plex Research and Ginkgo Bioworks, demonstrate the growing role of AI-powered drug repurposing, particularly in rare and orphan diseases.